课题基金 / 基金详情

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch
1/2 促进癌症研究的伙伴关系:NMSU
批准号:
10006785
负责人:
Julian A Simon
金额:
$115.48万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2023-08-31

项目摘要

项目成果

Julian A Simon的其他基金

相似基金

相关文献

中文摘要
翻译
癌症研究促进伙伴关系:NMSU-Fred Hutch 多重PI:Graciela A.Unguez,Mary O‘Connell(NMSU)和Julian Simon,Beti Thompson(Fred Hutch) [整个部分的内容在NMSU和Fred Hutch的提案中是相同的。] 项目摘要/摘要 新墨西哥州立大学(NMSU)与服务不足的机构之间的U54合作伙伴关系 健康差距,人口和代表不足的学生(ISUPS),以及弗雷德·哈钦森癌症 研究中心(Fred Hutch)是一家主要的癌症中心,是一种成熟的互惠合作伙伴关系;两者 各机构就U56(2002-2007年)和U54(2007-2018年)的两个周期进行了合作。在我们15年的时间里 通过合作,我们实现了许多目标;例如,NMSU现在拥有强大的癌症研究 基础设施和弗雷德·哈奇正在加大对健康差距研究的关注。我们对此的总体目标是 U54周期是为了增加和保持我们在癌症研究组合、癌症教育和 进一步,我们将加大力度,培养癌症研究和研究领域的领军人物 癌症健康差异研究。五个具体目标将帮助我们实现总体目标:(1)继续 开发多种强大的癌症研究项目组合,涵盖临床、基础和人群健康 科学;(2)与从事代表性不足人口工作的区域社区组织合作 减少癌症健康差距;(3)保持、加强和评估我们有效的研究教育 针对当前和未来任职人数不足的科学家的方案;(4)继续实施循证 在代表性不足的社区内开展与癌症相关的公共卫生干预措施;以及(5)扩大 U54伙伴关系成员和两个机构内的其他教员之间的科学合作。至 为了实现这些目标,我们已经组织了一系列创新的癌症研究项目(两个完整的 研究项目和两个试点研究项目),每个项目都解决以下方面未得到满足的区域需求 代表性不足的人群。最近对健康差距的强调代表着我们的重点发生了转变 从基础到公共卫生科学研究项目的伙伴关系。这些项目受益于强大的 社区意见。除了四个研究项目外,我们还提出了五个核心:行政、规划和 癌症与健康(REACH)评估、研究教育(REACH)、推广和保持竞争力 癌症早期科学家(SUCCESS)是推动癌症研究、教育、 社区协作、触手可及和外展。该伙伴关系已经并将继续发挥独特的和 在这两个机构努力增加招聘和留住任职人数不足的人员方面发挥关键作用 生物医学研究管道。此外,该伙伴关系还显著增加了癌症研究 NMSU的能力,同时也增加了对弗雷德·哈奇健康差距研究的参与-两者都 各机构从这一伙伴关系中受益匪浅。
英文摘要
Partnership for the Advancement of Cancer Research: NMSU – Fred Hutch Multiple PIs: Graciela A. Unguez, Mary O'Connell (NMSU) and Julian Simon, Beti Thompson (Fred Hutch) [The content of the Overall Section is identical in the NMSU and Fred Hutch proposals.] PROJECT SUMMARY/ABSTRACT The U54 Partnership between New Mexico State University (NMSU), an Institution Serving Underserved Health Disparities Populations and Underrepresented Students (ISUPS), and Fred Hutchinson Cancer Research Center (Fred Hutch) a major cancer center, is a mature mutually beneficial partnership; the two institutions worked together on a U56 (2002-2007) and two cycles of a U54 (2007 – 2018). In our 15-year Partnership, we have accomplished many goals; for example, NMSU now has a strong cancer research infrastructure and Fred Hutch is increasing its attention to health disparities research. Our overall goals for this U54 cycle are to increase and maintain our excellence in the cancer research portfolio, cancer education, and outreach and dissemination; further, we will expand our efforts to develop leaders in cancer research and cancer health disparities research. Five specific aims will help us achieve our overall goals to: (1) Continue to develop a diverse portfolio of robust cancer research projects that span clinical, basic, and population health sciences; (2) Collaborate with regional community organizations that work with underrepresented populations to reduce cancer health disparities; (3) Maintain, strengthen, and evaluate our effective research education programs for current and future underrepresented scientists; (4) Continue to implement evidence-based relevant cancer-related public health interventions within underrepresented communities; and (5) Expand the scientific collaboration among U54 Partnership members and other faculty within the two institutions. To achieve these aims, we have assembled a broad portfolio of innovative cancer research projects (two full research projects and two pilot research projects) that each address an unmet regional need among underrepresented populations. Recent emphasis on health disparities represents a shift in the focus of our Partnership from basic to public health science research projects. These projects benefit from strong community input. In addition to the four research projects, we propose five cores: Administrative, Planning and Evaluation, Research Education About Cancer and Health (REACH), Outreach and Sustain Competitive Cancer Early Stage Scientists (SuCCESS) Cores that promote the development of cancer research, education, community collaboration, in-reach, and outreach. The Partnership has and will continue to play a unique and critical role in both institutions' efforts to increase recruitment and retention of underrepresented individuals in the biomedical research pipeline. Additionally, the Partnership has significantly increased cancer research capacity at NMSU, while also increasing participation in health disparities research at Fred Hutch—both institutions have benefited substantially from the Partnership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
海外基金